Hatoshido

219A.TPharmaceutical

Filed as Heartseed Inc. (2025-01–2026-08)

Key numbers · FY ended 2025-12

Revenue¥3.0bn+246.4% YoY Operating income¥272m—Total assets¥7.7bn+8.6% YoY EPS (basic)¥8.44+117.1% YoY

Full financial history and reports →

Stock price219A · View chart ↗

Open the price chart on TradingView.

Latest filings

Fri, Sep 26 · JST1 filing

16:445% STAKEHatoshido · SBI Ventures Two Co., Ltd. + 2 joint holders · 13.81% → 12.79%−1.02pp

Wed, Sep 17 · JST1 filing

17:035% STAKEHatoshido · SBI Ventures Two Co., Ltd. + 2 joint holders · 14.96% → 13.81%−1.15pp

Fri, Aug 29 · JST1 filing

16:145% STAKEHatoshido · SBI Ventures Two Co., Ltd. + 2 joint holders · 16.16% → 14.96%−1.20pp

Fri, Aug 22 · JST1 filing

16:395% STAKEHatoshido · SBI Ventures Two Co., Ltd. + 2 joint holders · 17.56% → 16.16%−1.40pp

Thu, Jun 26 · JST1 filing

09:535% STAKEHatoshido · SBI Ventures Two Co., Ltd + 2 joint holders · 18.66% → 17.61%−1.05pp

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
FUKUDA KEIICHI	11.56%	-2.99pp	2026-08-28
SBI Ventures Two Co., Ltd.	9.82%	0.00pp	2025-09-26

Each holder's own ratio from its most recent large-shareholding report.